Correlation Between Icosavax and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Icosavax and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icosavax and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Icosavax and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Icosavax and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icosavax with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icosavax and Monte Rosa.
Diversification Opportunities for Icosavax and Monte Rosa
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Icosavax and Monte is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Icosavax and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Icosavax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icosavax are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Icosavax i.e., Icosavax and Monte Rosa go up and down completely randomly.
Pair Corralation between Icosavax and Monte Rosa
Given the investment horizon of 90 days Icosavax is expected to generate 8.86 times less return on investment than Monte Rosa. But when comparing it to its historical volatility, Icosavax is 1.18 times less risky than Monte Rosa. It trades about 0.0 of its potential returns per unit of risk. Monte Rosa Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 659.00 in Monte Rosa Therapeutics on November 2, 2024 and sell it today you would lose (2.00) from holding Monte Rosa Therapeutics or give up 0.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 22.67% |
| Values | Daily Returns |
Icosavax vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Monte Rosa Therapeutics |
Icosavax and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Icosavax and Monte Rosa
The main advantage of trading using opposite Icosavax and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icosavax position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
| Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |